等待开盘 08-05 09:30:00 美东时间
0.000
0.00%
Medera is a clinical-stage biotechnology company focused on targeting difficult-to-treat cardiovascular diseases using a range of next-generation gene- and cell-based approaches in combination with bioengineered human
2024-09-05 20:17